Search alternatives:
larger decrease » marked decrease (Expand Search)
large decreases » largest decreases (Expand Search), large increases (Expand Search), largest decrease (Expand Search)
laser decrease » linear decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a large » _ large (Expand Search)
Showing 161 - 180 results of 26,150 for search '(( via ((((laser decrease) OR (a decrease))) OR (larger decrease)) ) OR ( a large decreases ))', query time: 1.56s Refine Results
  1. 161
    Image_15_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF

    Image_15_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  2. 162
    Image_3_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF

    Image_3_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  3. 163
    Image_8_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF

    Image_8_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  4. 164
    Image_10_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF

    Image_10_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  5. 165
    Image_5_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF

    Image_5_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  6. 166
    Image_11_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF

    Image_11_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  7. 167
    Image_10_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF

    Image_10_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  8. 168
    Image_12_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF

    Image_12_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  9. 169
    Image_15_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF

    Image_15_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  10. 170
    Image_1_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF

    Image_1_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  11. 171
    Image_9_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF

    Image_9_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  12. 172
    Image_14_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF

    Image_14_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  13. 173
    Image_5_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF

    Image_5_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  14. 174
    Image_2_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF

    Image_2_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  15. 175
    CY-09 Alleviates the Depression-like Behaviors via Inhibiting NLRP3 Inflammasome-Mediated Neuroinflammation in Lipopolysaccharide-Induced Mice

    CY-09 Alleviates the Depression-like Behaviors via Inhibiting NLRP3 Inflammasome-Mediated Neuroinflammation in Lipopolysaccharide-Induced Mice by Yu Wang (12152)

    Published 2022
    “…Depression is a serious mental illness, mainly characterized as large mood swings and sleep, diet, and cognitive function disorders. …”
    Save to List
    Saved in:
  16. 176
    Continuous Viscoelasticity Measurement of Cell Spheroids via Microfluidic Electrical Aspiration

    Continuous Viscoelasticity Measurement of Cell Spheroids via Microfluidic Electrical Aspiration by Heyi Chen (19930197)

    Published 2024
    “…The use of a symmetric aspiration channel and the linear half-space model enable measurements of a large number of viscoelastic properties via a single measurement with higher accuracy. …”
    Save to List
    Saved in:
  17. 177
    AMPK regulates Fet-A expression by proteosomal degradation and decreased C/EBP beta expression.

    AMPK regulates Fet-A expression by proteosomal degradation and decreased C/EBP beta expression. by Vishal Kothari (12511601)

    Published 2022
    Save to List
    Saved in:
  18. 178
    Large Decreases in Tailpipe Criteria Pollutant Emissions from the U.S. Light-Duty Vehicle Fleet Expected in 2020–2040

    Large Decreases in Tailpipe Criteria Pollutant Emissions from the U.S. Light-Duty Vehicle Fleet Expected in 2020–2040 by Rachael H. Dolan (17918706)

    Published 2024
    “…Reductions in CO<sub>2</sub> emissions follow a similar pattern. Large decreases in criteria pollutant and CO<sub>2</sub> emissions from light duty vehicles lie ahead.…”
    Save to List
    Saved in:
  19. 179
    Large Decreases in Tailpipe Criteria Pollutant Emissions from the U.S. Light-Duty Vehicle Fleet Expected in 2020–2040

    Large Decreases in Tailpipe Criteria Pollutant Emissions from the U.S. Light-Duty Vehicle Fleet Expected in 2020–2040 by Rachael H. Dolan (17918706)

    Published 2024
    “…Reductions in CO<sub>2</sub> emissions follow a similar pattern. Large decreases in criteria pollutant and CO<sub>2</sub> emissions from light duty vehicles lie ahead.…”
    Save to List
    Saved in:
  20. 180
    Data_Sheet_1_Pulmonary Exposure to Magnéli Phase Titanium Suboxides Results in Significant Macrophage Abnormalities and Decreased Lung Function.PDF

    Data_Sheet_1_Pulmonary Exposure to Magnéli Phase Titanium Suboxides Results in Significant Macrophage Abnormalities and Decreased Lung Function.PDF by Dylan K. McDaniel (8054981)

    Published 2019
    Save to List
    Saved in:

Search Tools: